Christel Franchet
Corporate Officer/Principal en Domain Therapeutics SA .
Perfil
Christel Franchet is the founder of Euroclide SA, which was founded in 2001.
She is currently the Head of Biology Department at Domain Therapeutics SA. Dr. Franchet's former position was as a Principal at Hoffmann La Roche France in 2001.
She received a doctorate degree from the University of Strasbourg in 2001.
Cargos activos de Christel Franchet
Empresas | Cargo | Inicio |
---|---|---|
Domain Therapeutics SA
Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Christel Franchet.
Empresas | Cargo | Fin |
---|---|---|
Hoffmann La Roche France | Corporate Officer/Principal | 01/01/2001 |
Euroclide SA
Euroclide SA Miscellaneous Commercial ServicesCommercial Services Part of Domain Therapeutics SA, Euroclide SA is a French drug research company. The company was founded by Christel Franchet. Euroclide was acquired by Domain Therapeutics SA on December 22, 2003. | Fundador | - |
Formación de Christel Franchet.
University of Strasbourg | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Domain Therapeutics SA
Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Health Technology |
Euroclide SA
Euroclide SA Miscellaneous Commercial ServicesCommercial Services Part of Domain Therapeutics SA, Euroclide SA is a French drug research company. The company was founded by Christel Franchet. Euroclide was acquired by Domain Therapeutics SA on December 22, 2003. | Commercial Services |
Hoffmann La Roche France |
- Bolsa de valores
- Insiders
- Christel Franchet